BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 24524305)

  • 21. Expression and prognosis analysis of
    Zhang T; Zhao Y; Zhao Y; Zhou J
    Aging (Albany NY); 2020 Mar; 12(6):5031-5047. PubMed ID: 32209730
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic Significance of Fms-Like Tyrosine Kinase 3 Internal Tandem Duplication Mutation in Non-Transplant Adult Patients with Acute Myeloblastic Leukemia: A Systematic Review and Meta-Analysis.
    Rinaldi I; Louisa M; Wiguna FI; Budiani E; Mahardhika JC; Hukmi K
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2827-2836. PubMed ID: 33112537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of ASXL1 mutations in acute myeloid leukemia: A meta-analysis.
    Lipilkin PV; Kulaeva ED; Mashkina EV
    Leuk Res; 2022 Sep; 120():106910. PubMed ID: 35785697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.
    Abdel-Wahab O; Mullally A; Hedvat C; Garcia-Manero G; Patel J; Wadleigh M; Malinge S; Yao J; Kilpivaara O; Bhat R; Huberman K; Thomas S; Dolgalev I; Heguy A; Paietta E; Le Beau MM; Beran M; Tallman MS; Ebert BL; Kantarjian HM; Stone RM; Gilliland DG; Crispino JD; Levine RL
    Blood; 2009 Jul; 114(1):144-7. PubMed ID: 19420352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of TET2 SNP rs2454206 with improved survival in children with acute myeloid leukemia featuring intermediate-risk cytogenetics.
    Wang X; Chen X; Yang Z; Dou H; Lu L; Bi J; Zou L; Yu J; Bao L
    Genes Chromosomes Cancer; 2018 Aug; 57(8):379-386. PubMed ID: 29664232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia.
    Ahn JS; Kim HJ; Kim YK; Lee SS; Ahn SY; Jung SH; Yang DH; Lee JJ; Park HJ; Choi SH; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Michael S; Minden MD; Kim DD
    Oncotarget; 2017 Jan; 8(5):8305-8314. PubMed ID: 28039446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of clinical significance and prognostic impact of TET2 single nucleotide polymorphism I1762V in patients with acute myeloid leukemia].
    Li YW; Guo Z; Wang LL; Zhou L; Lyu XD; Song YP
    Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):241-246. PubMed ID: 35405783
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical characteristics and prognostic study of adult acute myeloid leukemia patients with
    Lin Y; Wang Y; Zheng Y; Wang Z; Wang Y; Wang S
    Hematology; 2020 Dec; 25(1):446-456. PubMed ID: 33250015
    [No Abstract]   [Full Text] [Related]  

  • 29. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.
    Ponciano-Gómez A; Martínez-Tovar A; Vela-Ojeda J; Olarte-Carrillo I; Centeno-Cruz F; Garrido E
    Tumour Biol; 2017 Oct; 39(10):1010428317732181. PubMed ID: 28992762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms.
    Scopim-Ribeiro R; Machado-Neto JA; de Melo Campos P; Niemann FS; Lorand-Metze I; Costa FF; Olalla Saad ST; Traina F
    Diagn Pathol; 2016 Mar; 11():28. PubMed ID: 26984174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysis.
    Port M; Böttcher M; Thol F; Ganser A; Schlenk R; Wasem J; Neumann A; Pouryamout L
    Ann Hematol; 2014 Aug; 93(8):1279-86. PubMed ID: 24801015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TET2 and MEG3 promoter methylation is associated with acute myeloid leukemia in a Hainan population.
    Yao H; Duan M; Lin L; Wu C; Fu X; Wang H; Guo L; Chen W; Huang L; Liu D; Rao R; Wang S; Ding Y
    Oncotarget; 2017 Mar; 8(11):18337-18347. PubMed ID: 28407691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of ASXL1 mutations in patients with myelodysplastic syndromes and acute myeloid leukemia: A meta-analysis.
    Zhang A; Wang S; Ren Q; Wang Y; Jiang Z
    Asia Pac J Clin Oncol; 2023 Oct; 19(5):e183-e194. PubMed ID: 36471477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of
    Ye W; Ma M; Wu X; Deng J; Liu X; Zheng X; Gong Y
    BMJ Open; 2023 Feb; 13(2):e062376. PubMed ID: 36725100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute myeloid leukaemia: recent data on prognostic gene mutations, in relation to stratified therapies for elderly patients.
    Soura EN; Karikas GA
    J BUON; 2019; 24(4):1326-1339. PubMed ID: 31646775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of vascular endothelial growth factor expression in adult patients with acute myeloid leukemia: a meta-analysis.
    Guo B; Liu Y; Tan X; Cen H
    Leuk Lymphoma; 2013 Jul; 54(7):1418-25. PubMed ID: 23157271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
    Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
    J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does
    Song J; Moscinski L; Zhang H; Zhang X; Hussaini M
    Cancer Genomics Proteomics; 2019; 16(1):91-98. PubMed ID: 30587503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic role of TET2 deficiency in myelodysplastic syndromes: A meta-analysis.
    Lin Y; Lin Z; Cheng K; Fang Z; Li Z; Luo Y; Xu B
    Oncotarget; 2017 Jun; 8(26):43295-43305. PubMed ID: 28476038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation.
    Ahn JS; Kim HJ; Kim YK; Lee SS; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):61-70. PubMed ID: 26234722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.